FDA Clearance Tracker · P060025-S002
ATS 3F AORTIC BIOPROSTHESIS MODEL 1000
Last checked: Nov 20, 2026Latest source record: Aug 21, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Aug 21, 2019
Approved
Time to decision
3,920 days
Received Nov 26, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P060025-S002
- Device name
- ATS 3F AORTIC BIOPROSTHESIS MODEL 1000
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Nov 26, 2008
- Decided
- Aug 21, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P060025
Device type
- Device type
- heart-valve, non-allograft tissue (LWR)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.